AMBALAL SARABHAI share price has zoomed 7% and is presently trading at Rs 58.3.
Meanwhile, the BSE HEALTHCARE index is at 44,095.2 (down 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 6.5%) and GRANULES INDIA (up 3.7%).
Aurobindo Pharma (down 2.1%) and Pfizer (down 2.1%) are among the top losers today.
Over the last one year, AMBALAL SARABHAI has moved up from Rs 37.9 to Rs 58.3, registering a gain of Rs 20.3 (up 53.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,071.8 to 44,095.2, registering a gain of 57.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 170.7%), SUVEN PHARMACEUTICALS (up 125.3%) and Glenmark Pharma (up 114.8%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 84,249.8 (down 0.1%).
The top losers among the BSE Sensex today are Indusind Bank (down 2.0%) and Asian Paints (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..
In the meantime, NSE Nifty is at 25,771.1 (down 0.2%). Indusind Bank and Asian Paints are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,118.7 to 84,249.8, registering a gain of 18,131.1 points (up 27.4%).
AMBALAL SARABHAI net profit grew 118.2% YoY to Rs 7 million for the quarter ended June 2024, compared to a loss of Rs 39 million a year ago. Net sales rose 12.7% to Rs 407 million during the period as against Rs 361 million in April-June 2023.
For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.
The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 34.3.
Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 7%; BSE HEALTHCARE Index Down 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!